Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-22-013911
Filing Date
2022-07-12
Accepted
2022-07-12 16:26:33
Documents
2
Period of Report
2022-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 1873
2 POWER OF ATTORNEY baluchpoa.txt EX-24.1 3732
  Complete submission text file 0001567619-22-013911.txt   7069
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1430 US HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address
Baluch Khoso (Reporting) CIK: 0001686223 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39531 | Film No.: 221079387